An Interactive Discussion on Managing a Patient with Substance Use Disorder: When the Goals of the Patient and Clinician Differ - May 18, 2022
Thank you for participating in this program. Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to complete the evaluation and claim your credit on the following page.
Primary care physicians, internists, family practice physicians, nurse practitioners, nurses, and physician assistants
Upon completion of this activity, participants will be able to:
- Summarize key components of a history presented for a MCSTAP consultation on a patient with SUD
- Describe how to develop and implement a treatment plan when the clinician and patient have different goals
- Describe approaches to use in engaging patients in the planning process of their treatment plan
Topic: Kratom Use Complicating Treatment of Substance Use Disorder
Presenter: Christopher Shanahan, MD, MPH, FACP, MCSTAP medical director
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Boston University School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program meets the criteria of the Massachusetts Board of Registration in Medicine for 1 hour of opioid education.
CME Course Director: Christopher Shanahan, MD, MPH, FACP
ADA statement: To request reasonable accommodations for a disability please contact MCSTAP@beaconhealthoptions.com, in writing, at least two weeks prior to the activity.
- 1.00 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 MA Opioid Education Statement
- 1.00 Participation